Published in Catheter Cardiovasc Interv on July 15, 2011
Murphy's law and us. Catheter Cardiovasc Interv (2011) 0.75
Early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention improved 30-day clinical outcomes in patients with ST-segment elevation myocardial infarction complicated with profound cardiogenic shock. Crit Care Med (2010) 2.17
Bone marrow-derived mononuclear cell therapy alleviates left ventricular remodeling and improves heart function in rat-dilated cardiomyopathy. Crit Care Med (2009) 1.84
Cardiac rupture complicating acute myocardial infarction in the direct percutaneous coronary intervention reperfusion era. Chest (2003) 1.75
Prognostic value of circulating levels of endothelin-1 in patients after acute myocardial infarction undergoing primary coronary angioplasty. Chest (2005) 1.60
Outcomes of patients with Killip class III acute myocardial infarction after primary percutaneous coronary intervention. Crit Care Med (2011) 1.54
Long-term outcomes of intervention for unprotected left main coronary artery stenosis: coronary stenting vs coronary artery bypass grafting. Circ J (2009) 1.53
Delayed post-myocardial infarction invasive measures, helpful or harmful? A subgroup analysis. Chest (2004) 1.51
Application of penetration device (Tornus) for percutaneous coronary intervention in balloon uncrossable chronic total occlusion-procedure outcomes, complications, and predictors of device success. Catheter Cardiovasc Interv (2011) 1.49
Safety and efficacy of transradial vs transfemoral arterial primary coronary angioplasty for acute myocardial infarction: single-center experience. Circ J (2009) 1.49
Intracoronary Transfusion of Circulation-Derived CD34+ Cells Improves Left Ventricular Function in Patients With End-Stage Diffuse Coronary Artery Disease Unsuitable for Coronary Intervention. Crit Care Med (2015) 1.43
Minimizing door-to-balloon time is not the most critical factor in improving clinical outcome of ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention. Crit Care Med (2014) 1.41
Complete stent dislodgement after successful implantation--a rare case. Catheter Cardiovasc Interv (2010) 1.40
Comparison of 30-day mortality between anterior-wall versus inferior-wall ST-segment elevation myocardial infarction complicated by cardiogenic shock in patients undergoing primary coronary angioplasty. Cardiology (2010) 1.40
Transradial carotid stenting in a patient with bovine arch anatomy. Catheter Cardiovasc Interv (2010) 1.38
Left atrial platelet activity with rheumatic mitral stenosis: correlation study of severity and platelet P-selectin expression by flow cytometry. Chest (2003) 1.19
Intra-coronary administration of cyclosporine limits infarct size, attenuates remodeling and preserves left ventricular function in porcine acute anterior infarction. Int J Cardiol (2009) 1.13
Treatment of aortocoronary dissection complicating anomalous origin right coronary artery and chronic total intervention with intravascular ultrasound guided stenting. Catheter Cardiovasc Interv (2011) 1.11
Polymer-based, paclitaxel-eluting TAXUS Liberté stent in de novo lesions: the pivotal TAXUS ATLAS trial. J Am Coll Cardiol (2007) 1.04
Percutaneous coronary intervention for iatrogenic left main coronary artery dissection. Int J Cardiol (2007) 1.02
Left main coronary artery bidirectional dissection caused by ejection of guideliner catheter from the guiding catheter. Catheter Cardiovasc Interv (2013) 1.00
Predictors of contrast-induced nephropathy in chronic total occlusion percutaneous coronary intervention. EuroIntervention (2014) 0.99
Sildenafil limits monocrotaline-induced pulmonary hypertension in rats through suppression of pulmonary vascular remodeling. J Cardiovasc Pharmacol (2010) 0.98
Autologous transplantation of bone marrow-derived endothelial progenitor cells attenuates monocrotaline-induced pulmonary arterial hypertension in rats. Crit Care Med (2008) 0.97
Early combined treatment with sildenafil and adipose-derived mesenchymal stem cells preserves heart function in rat dilated cardiomyopathy. J Transl Med (2010) 0.96
Levels and values of serum high-sensitivity C-reactive protein within 6 hours after the onset of acute myocardial infarction. Chest (2004) 0.96
Clinical features and outcome of coronary artery aneurysm in patients with acute myocardial infarction undergoing a primary percutaneous coronary intervention. Cardiology (2002) 0.94
Migrating type A intramural hematoma after repair of an anomalous right coronary artery aortocoronary dissection with a covered stent. Catheter Cardiovasc Interv (2011) 0.94
Autologous bone marrow cell implantation attenuates left ventricular remodeling and improves heart function in porcine myocardial infarction: an echocardiographic, six-month angiographic, and molecular-cellular study. Int J Cardiol (2010) 0.93
Effect of the PercuSurge GuardWire device on the integrity of microvasculature and clinical outcomes during primary transradial coronary intervention in acute myocardial infarction. Am J Cardiol (2003) 0.92
Transradial intracoronary catheter-aspiration embolectomy for acute coronary embolism after mitral valve replacement. Tex Heart Inst J (2003) 0.92
Extracorporeal shock wave therapy reverses ischemia-related left ventricular dysfunction and remodeling: molecular-cellular and functional assessment. PLoS One (2011) 0.91
The potential impact of primary percutaneous coronary intervention on ventricular septal rupture complicating acute myocardial infarction. Chest (2004) 0.90
Prognostic factors and outcomes in young chinese patients with acute myocardial infarction undergoing primary coronary angioplasty. Int Heart J (2009) 0.90
Value and level of galectin-3 in acute myocardial infarction patients undergoing primary percutaneous coronary intervention. J Atheroscler Thromb (2012) 0.88
A single transradial guiding catheter for right and left coronary angiography and intervention. EuroIntervention (2008) 0.88
Level and prognostic value of serum myeloperoxidase in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Circ J (2009) 0.87
Estimated glomerular filtration rate as a useful predictor of mortality in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Am J Med Sci (2013) 0.87
Obesity suppresses circulating level and function of endothelial progenitor cells and heart function. J Transl Med (2012) 0.87
Utilization of a double-wire technique to treat long extended spiral dissection of the right coronary artery. Evaluation of incidence and mechanisms. Int Heart J (2005) 0.87
Level and value of circulating endothelial progenitor cells in patients with acute myocardial infarction undergoing primary coronary angioplasty: in vivo and in vitro studies. Transl Res (2010) 0.87
The prognostic value of atrial fibrillation on 30-day clinical outcome in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Int Heart J (2011) 0.86
Long-term effects of baroreflex function after stenting in patients with carotid artery stenosis. Auton Neurosci (2010) 0.86
Losartan preserves integrity of cardiac gap junctions and PGC-1 alpha gene expression and prevents cellular apoptosis in remote area of left ventricular myocardium following acute myocardial infarction. Int Heart J (2007) 0.86
Shock wave therapy effectively attenuates inflammation in rat carotid artery following endothelial denudation by balloon catheter. Cardiology (2009) 0.85
Link between lipoprotein-associated phospholipase A2 gene expression of peripheral-blood mononuclear cells and prognostic outcome after acute ischemic stroke. J Atheroscler Thromb (2012) 0.85
Comparison of prognostic outcome between left circumflex artery-related and right coronary artery-related acute inferior wall myocardial infarction undergoing primary percutaneous coronary intervention. Clin Cardiol (2011) 0.85
Impact of clopidogrel on suppression of circulating levels of soluble CD40 ligand in patients with unstable angina undergoing coronary stenting. Am J Cardiol (2005) 0.85
Balance between plasma levels of tumor necrosis factor-alpha and interleukin-10 in rheumatic mitral stenosis. Cardiology (2005) 0.85
Impact of obesity control on circulating level of endothelial progenitor cells and angiogenesis in response to ischemic stimulation. J Transl Med (2012) 0.84
Early erythropoietin therapy attenuates remodeling and preserves function of left ventricle in porcine myocardial infarction. J Investig Med (2011) 0.84
Impact of diabetes on cardiomyocyte apoptosis and connexin43 gap junction integrity: role of pharmacological modulation. Int Heart J (2007) 0.83
Serial changes in circulating concentrations of soluble CD40 ligand and C-reactive protein in patients with unstable angina undergoing coronary stenting. Circ J (2005) 0.83
Early administration of intracoronary verapamil improves myocardial perfusion during percutaneous coronary interventions for acute myocardial infarction. Chest (2005) 0.83
Increased circulating endothelin-1 in rheumatic mitral stenosis: irrelevance to left atrial and pulmonary artery pressures. Chest (2004) 0.83
Impact of hyperglycemic control on left ventricular myocardium. A molecular and cellular basic study in a diabetic rat model. Int Heart J (2009) 0.83
Primary percutaneous coronary intervention lowers the incidence of ischemic mitral regurgitation in patients with acute ST-elevated myocardial infarction. Circ J (2010) 0.83
Strong correlation between serum levels of inflammatory mediators and their distribution in infarct-related coronary artery. Circ J (2006) 0.83
Transient contrast encephalopathy after carotid artery stenting mimicking diffuse subarachnoid hemorrhage: a case report. Catheter Cardiovasc Interv (2009) 0.82
Feasibility and safety of transradial stenting for unprotected left main coronary artery stenoses. Circ J (2007) 0.82
Clinical profile and outcome of first acute myocardial infarction with ischemic mitral regurgitation. Chang Gung Med J (2008) 0.81
Bilateral cardiac catheterizations: the safety and feasibility of a superficial forearm venous and transradial arterial approach. Int Heart J (2006) 0.81
No age-related change in circulating endothelial progenitor cells in healthy subjects. Int Heart J (2006) 0.81
Acute myocardial infarction with simultaneous ST-segment elevation in the precordial and inferior leads: evaluation of anatomic lesions and clinical implications. Chest (2003) 0.81
Prognostic value of circulating dead monocytes in patients with acute st-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Cardiology (2010) 0.81
Benefit of revascularization in non-infarct-related artery in multivessel disease patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Int Heart J (2010) 0.81
Myocardium-derived conditioned medium improves left ventricular function in rodent acute myocardial infarction. J Transl Med (2011) 0.80
Impact of simvastatin and losartan on antiinflammatory effect: in vitro study. J Cardiovasc Pharmacol (2007) 0.80
Comparison of primary angioplasty and conservative treatment on short- and long-term outcome in octogenarian or older patients with acute myocardial infarction. Jpn Heart J (2002) 0.80
Strong suppression of high-sensitivity C-reactive protein level and its mediated pro-atherosclerotic effects with simvastatin: in vivo and in vitro studies. Int J Cardiol (2006) 0.80
Prognostic value of activated toll-like receptor-4 in monocytes following acute myocardial infarction. Int Heart J (2008) 0.80
Gender differences in patients undergoing coronary stenting in current stent era. Chin Med J (Engl) (2011) 0.80
Levels and values of inflammatory markers in patients with angina pectoris. Int Heart J (2005) 0.80
Interleukin-18: a strong predictor of the extent of coronary artery disease in patients with unstable angina. Heart Vessels (2007) 0.80
Transradial approach percutaneous coronary interventions in an out-patient clinic. Int Heart J (2010) 0.79
The feasibility and safety of early discharge for low risk patients with acute myocardial infarction after successful direct percutaneous coronary intervention. Jpn Heart J (2003) 0.79
Impact of PercuSurge device conjugative with intracoronary administration of nitroprusside on no-reflow phenomenon following primary percutaneous coronary intervention. Circ J (2006) 0.79
Platelet activation in patients with chronic nonvalvular atrial fibrillation. Int Heart J (2006) 0.79
Level and value of interleukin-18 in patients with acute myocardial infarction undergoing primary coronary angioplasty. Circ J (2007) 0.79
Revascularization of a central vein total occlusion via antegrade and retrograde approach in a patient with hemodialysis access. Catheter Cardiovasc Interv (2010) 0.78
Endothelial dysfunction in young patients with acute ST-elevation myocardial infarction. Heart Vessels (2010) 0.78
The predictors of successful percutaneous coronary intervention in ostial left anterior descending artery chronic total occlusion. Catheter Cardiovasc Interv (2014) 0.78
Circulating levels of soluble P-selectin in patients in the early and recent phases of myocardial infarction. Chang Gung Med J (2005) 0.78
Major adverse upper gastrointestinal events in patients with ST-segment elevation myocardial infarction undergoing primary coronary intervention and dual antiplatelet therapy. Am J Cardiol (2011) 0.78
Immediate results of percutaneous coronary intervention for unprotected left main coronary artery stenoses: transradial versus transfemoral approach. Chang Gung Med J (2008) 0.78
Concurrent antegrade transseptal Inoue-balloon mitral and aortic valvuloplasty. Catheter Cardiovasc Interv (2013) 0.78
Can a penetration catheter (Tornus) substitute traditional rotational atherectomy for recanalizing chronic total occlusions? Int Heart J (2010) 0.78
Transradial and transbrachial arterial approach for simultaneous carotid angiographic examination and stenting using catheter looping and retrograde engagement technique. Ann Vasc Surg (2010) 0.78